Fundraise
Summary by AI BETAClose X
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION
29 August 2025
ACCELER8 VENTURES PLC
Fundraise
Acceler8 Ventures Plc (LSE: AC8, "AC8" or the "Company"), the Main Market listed acquisition company, announces that further to the announcement made on 17 June 2025, AC8 has successfully raised £380,000 through the issue of unsecured Convertible Loan Notes ("CLNs").
The CLNs have been issued to new incoming investors in order to raise funds to support the Company's modest working capital requirements in pursuit of an initial transaction.
The principal terms of the CLNs are as follows:
Amount: £380,000
Interest rate: 8 per cent. per annum, payable-in-kind and compounding annually
Redemption: No redemption rights applicable save for agreement by the Noteholder following a tender offer by the Company
Conversion: Automatic conversion of principal and accrued interest on the earlier of completion of an Initial Transaction (as defined by UKLR 13.4.1) and the third anniversary of CLN issuance
Conversion price: The lower of £1 per Ordinary Share and a 30 per cent. discount to the prevailing price per Ordinary Share applicable to the Initial Transaction, or a 30 per cent. discount to a 20-trading day VWAP as at close on the last trading day prior to the third anniversary of CLN issuance
Security: The CLNs will rank pari passu with other unsecured creditors of the Company
Inside Information
This announcement contains inside information as defined in Regulation (EU) No. 596/2014 on market abuse which is part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is made in accordance with the Company's obligations under article 17 of MAR. The person responsible for arranging the release of this announcement on behalf of AC8 is David Williams, Chairman of AC8.
Enquiries:
|
Tessera Investment Management Limited |
|
|
Tony Morris |
+44 (0) 7742 189145 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 47 minutes ago Frasers Group
- 47 minutes ago Cavendish Financial
- 47 minutes ago Diaceutics
- 47 minutes ago AB Dynamics
- 14 hours ago Johnson Matthey